DHNQ T27163
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
DHNQ is a novel inhibitor of the PI3K enzyme activity and transcriptional as well as translational expression levels in colorectal cancer (CRC).
CAS nr:
31785-60-1
Purity:
98%
Molecular Weight:
274,32
SMILES:
O=C1NC(C2=C3C=CC=CC3=CC=C2)NC4=C1C=CC=C4
Formula:
C18H14N2O
Pathway:
Target:
